GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

SNUS-PH · Jun 30, 2022

Santander Holdings USA, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000811830-22-000033Bank
Sequential deposit growth10thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

-5.24% · CORE · VALID

Net-income growth20thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

-54.25% · CORE · VALID

Interest-expense growth90thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_expense

32.22% · CORE · VALID

Interest-income growth80thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

5.11% · CORE · VALID

Cash and equivalents53thOwn-history percentile · N=17
Evidence method

Level · gp.fundamentals.cash

$10.5B · CORE · VALID

Sequential loan growth60thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

0.98% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History65 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Decreased
Previous
-3.69%
Current
-5.24%
Delta
-1.55%
Liquidity Decreased
Previous
$13.5B
Current
$10.5B
Delta
-$3.1B
Loan Growth Increased
Previous
-0.29%
Current
0.98%
Delta
1.26%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.